The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSS Locally Advanced Rectal Cancer

NCT04411537 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Rectal Cancer

Interventions

DRUG: PD-1 antibody
DRUG: Capecitabine
DRUG: Irinotecan
RADIATION: Neoadjuvant Radiotherapy

Sponsor

Fudan University